Ascorbic acid Completed Phase 2 Trials for Occluded Totally Implanted Central Venous Catheter

IndicationsStatusPurposePhase
CompletedNot Available2
clinicaltrials.gov IdentifierTitleDrugs
NCT01270152Determining the Safe Dosage of Ascorbic Acid Used in the Treatment of Occluded Totally Implanted Central Venous Catheter